Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Bristol Myers Squibb (BMY) is undervalued and poised for growth, with strong dividends and robust financials. Read here for ...

Bristol Myers Squibb BMY and Amgen AMGN are among the largest global biotechnology companies with broad and diverse ...

Furthermore, the firm sees favorable risk/reward as Bristol-Myers Squibb Company (NYSE:BMY) approaches 2026 filled with ...

Bristol-Myers Squibb's key drugs are losing patent protection, while more recently launched drugs are struggling to meet peak ...

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Achievers List. Several of the largest US and European drugmakers struck agreements with President Donald Trump ...

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Bristol-Myers Squibb Company is one of the ...